Breast screening programme extended to Gozo
The breast screening programme has been extended to Gozo, while, in Malta, a second mammography machine will be purchased to increase the screening rate, Health Minister Josseph Cassar said today.
Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more than six months compared to women treated with a standard therapy of anastrozole alone.